These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 17336390)

  • 21. Structure-activity studies of non-steroid analogues structurally-related to neuroprotective estrogens.
    Qian M; Engler-Chiurazzi EB; Lewis SE; Rath NP; Simpkins JW; Covey DF
    Org Biomol Chem; 2016 Oct; 14(41):9790-9805. PubMed ID: 27714297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estrogen-like compounds for ischemic neuroprotection.
    Simpkins JW; Yang SH; Liu R; Perez E; Cai ZY; Covey DF; Green PS
    Stroke; 2004 Nov; 35(11 Suppl 1):2648-51. PubMed ID: 15472107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone.
    Roof RL; Hall ED
    J Neurotrauma; 2000 May; 17(5):367-88. PubMed ID: 10833057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen-astrocyte interactions: implications for neuroprotection.
    Dhandapani KM; Brann DW
    BMC Neurosci; 2002 Jun; 3():6. PubMed ID: 12067420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanistic investigations on the antioxidant action of a neuroprotective estrogen derivative.
    Prokai-Tatrai K; Perjesi P; Rivera-Portalatin NM; Simpkins JW; Prokai L
    Steroids; 2008 Mar; 73(3):280-8. PubMed ID: 18068745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocrine disruption via estrogen receptors that participate in nongenomic signaling pathways.
    Watson CS; Jeng YJ; Guptarak J
    J Steroid Biochem Mol Biol; 2011 Oct; 127(1-2):44-50. PubMed ID: 21300151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection.
    Prokai L; Prokai-Tatrai K; Perjesi P; Zharikova AD; Perez EJ; Liu R; Simpkins JW
    Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11741-6. PubMed ID: 14504383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurotrophic and neuroprotective actions of estrogen: basic mechanisms and clinical implications.
    Brann DW; Dhandapani K; Wakade C; Mahesh VB; Khan MM
    Steroids; 2007 May; 72(5):381-405. PubMed ID: 17379265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-oxidative neuroprotection by estrogens in mouse cortical cultures.
    Bae YH; Hwang JY; Kim YH; Koh JY
    J Korean Med Sci; 2000 Jun; 15(3):327-36. PubMed ID: 10895977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective effects of estradiol in mesencephalic dopaminergic neurons.
    Sawada H; Shimohama S
    Neurosci Biobehav Rev; 2000 Jan; 24(1):143-7. PubMed ID: 10654671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotective effects of estrogen and selective estrogen receptor modulators begin at the plasma membrane.
    Sheldahl LC; Marriott LK; Bryant DM; Shapiro RA; Dorsa DM
    Minerva Endocrinol; 2007 Jun; 32(2):87-94. PubMed ID: 17557034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen exerts neuroprotective effects via membrane estrogen receptors and rapid Akt/NOS activation.
    Alexaki VI; Charalampopoulos I; Kampa M; Vassalou H; Theodoropoulos P; Stathopoulos EN; Hatzoglou A; Gravanis A; Castanas E
    FASEB J; 2004 Oct; 18(13):1594-6. PubMed ID: 15289442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of estrogens on neurodegenerative processes.
    Członkowska A; Ciesielska A; Joniec I
    Med Sci Monit; 2003 Oct; 9(10):RA247-56. PubMed ID: 14523340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A case for estrogen receptors on cell membranes and nongenomic actions of estrogen.
    Monroe DG; Spelsberg TC
    Calcif Tissue Int; 2003 Mar; 72(3):183-4. PubMed ID: 12522664
    [No Abstract]   [Full Text] [Related]  

  • 35. Nongenomic actions of estrogens: exciting opportunities for pharmacology.
    Wehling M; Schultz A; Lösel R
    Maturitas; 2006 Jul; 54(4):321-6. PubMed ID: 16730139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen receptor-independent neuroprotection via protein phosphatase preservation and attenuation of persistent extracellular signal-regulated kinase 1/2 activation.
    Yi KD; Cai ZY; Covey DF; Simpkins JW
    J Pharmacol Exp Ther; 2008 Mar; 324(3):1188-95. PubMed ID: 18089844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Signaling by estrogens.
    Cheskis BJ; Greger JG; Nagpal S; Freedman LP
    J Cell Physiol; 2007 Dec; 213(3):610-7. PubMed ID: 17886255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogens and neuroprotection in retinal diseases.
    Kumar DM; Simpkins JW; Agarwal N
    Mol Vis; 2008 Aug; 14():1480-6. PubMed ID: 18698377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estrogen as a multi-active neuroprotective agent in traumatic injuries.
    Sribnick EA; Ray SK; Banik NL
    Neurochem Res; 2004 Nov; 29(11):2007-14. PubMed ID: 15662835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of nonfeminizing estrogen analogues in neuroprotection of rat retinal ganglion cells against glutamate-induced cytotoxicity.
    Kumar DM; Perez E; Cai ZY; Aoun P; Brun-Zinkernagel AM; Covey DF; Simpkins JW; Agarwal N
    Free Radic Biol Med; 2005 May; 38(9):1152-63. PubMed ID: 15808412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.